1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases

Details for Australian Patent Application No. 2007231594 (hide)

Owner Amgen Inc.

Inventors Yan, Xuelei; Sun, Daqing; Powers, Jay P.

Agent Knightsbridge Patent Attorneys

Pub. Number AU-A-2007231594

PCT Pub. Number WO2007/111921

Priority 60/784,753 23.03.06 US

Filing date 22 March 2007

Wipo publication date 4 October 2007

International Classifications

C07D 295/22 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/24 (2006.01) Drugs for disorders of the endocrine system

A61P 5/46 (2006.01) Drugs for disorders of the endocrine system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 213/46 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 307/46 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/22 (1970.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/111921 Priority application(s): WO2007/111921

21 April 2011 Section 223 Application Allowed

  Amgen Inc. The time in which to request examination has been extended to 28 Mar 2011. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000 2008

18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007231601-Real estate derivative financial products, index design, trading methods, and supporting computer systems

2007231591-Heat processing systems, apparatuses, and methods for collection and disposal of infectious and medical waste